Chemical formula: C₁₉H₁₆F₂N₈O₂ Molecular mass: 426.388 g/mol
Vericiguat is indicated for:
Population group: only adults (18 years old or older)
Vericiguat is indicated for the treatment of symptomatic chronic heart failure in adult patients with reduced ejection fraction who are stabilised after a recent decompensation event requiring IV therapy.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Vericiguat is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
